Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jun 28, 2008; 14(24): 3879-3883
Published online Jun 28, 2008. doi: 10.3748/wjg.14.3879
Published online Jun 28, 2008. doi: 10.3748/wjg.14.3879
Table 1 Serum concentrations (pg/mL) of VEGF-A, -C, and -D, and VEGFR-1 and -2 in patients with gastric adenocarcinoma and control subjects (n=76)
| Patients | Control | P | |
| VEGF-A | 585.7 ± 408.4; | 444.9 ± 328.9; | 0.02 |
| 469.31 (44.1-1927.7) | 346.9 (31.1-630.6) | ||
| VEGF-C | 6141.0 ± 2456.1; | 6067.8 ± 2219.3; | 0.88 |
| 5858.41 (970.4-12 158.9) | 5872.3 (711.7-12 158.9) | ||
| VEGF-D | 483.0 ± 259.3; | 671.1 ± 501.8; | 0.004 |
| 428.91 (205.7-1355.2) | 605.9 (205.7-3859.7) | ||
| VEGFR-1 | 873.7 ± 360.8; | 645.3 ± 297.9; | 0.0001 |
| 1026.41 (279.4-1767.6) | 475.4 (224.1-1333.6) | ||
| VEGFR-2 | 9266.5 ± 2 111.1; | 9420.3 ± 1840.7; | 0.45 |
| 9382.31 (4726.1-15 427.3) | 9386.2 ( 5727.9-15 433.3) |
- Citation: Al-Moundhri MS, Al-Shukaili A, Al-Nabhani M, Al-Bahrani B, Burney I, Rizivi A, Ganguly S. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma. World J Gastroenterol 2008; 14(24): 3879-3883
- URL: https://www.wjgnet.com/1007-9327/full/v14/i24/3879.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.3879